(Q51337900)

3 April 2018

title

Warfarin pharmacogenetics: development of a dosing algorithm for Omani patients. (English)

1 reference

3 April 2018

0 references

1 reference

Claudine Lapoumeroulie

7

1 reference

3 April 2018

Anil V Pathare

object named as

Anil Pathare

1

0 references

author name string

Murtadha Al Khabori

2

1 reference

3 April 2018

Salam Alkindi

3

1 reference

3 April 2018

Shoaib Al Zadjali

4

1 reference

3 April 2018

Rhea Misquith

5

1 reference

3 April 2018

Hammad Khan

6

1 reference

3 April 2018

Andras Paldi

8

1 reference

3 April 2018

Rajagopal Krishnamoorthy

9

1 reference

3 April 2018

publication date

2 August 2012

1 reference

3 April 2018

Journal of Human Genetics

published in

1 reference

3 April 2018

volume

57

1 reference

3 April 2018

issue

10

1 reference

3 April 2018

page(s)

665-669

1 reference

3 April 2018

Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2012.94

Estimation of the warfarin dose with clinical and pharmacogenetic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2012.94

Pharmacogenetics of warfarin: development of a dosing algorithm for brazilian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2012.94

Population diversity and the performance of warfarin dosing algorithms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2012.94

Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2012.94

Effects of CYP2C9 and VKORC1 on INR variations and dose requirements during initial phase of anticoagulant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2012.94

Genetic and clinical predictors of warfarin dose requirements in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2012.94

Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2012.94

The largest prospective warfarin-treated cohort supports genetic forecasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2012.94

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2012.94

Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2012.94

Dosing algorithms to predict warfarin maintenance dose in Caucasians and African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2012.94

Interethnic variability of warfarin maintenance requirement is explained by VKORC1 genotype in an Asian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2012.94

Impact of CYP4F2 rs2108622 on the stable warfarin dose in an admixed patient cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2012.94

CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2012.94

Race and ancestry in biomedical research: exploring the challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2012.94

Warfarin pharmacogenetics: polymorphisms of the CYP2C9, CYP4F2, and VKORC1 loci in a genetically admixed Omani population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2012.94

A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2012.94

A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2012.94

A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2012.94

Estimation of warfarin maintenance dose based on VKORC1 (-1639 G>A) and CYP2C9 genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2012.94

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/JHG.2012.94

1 reference

3 April 2018

1 reference

3 April 2018